Other venture-backed companies like Chai Discovery and Isomorphic Labs have raced to build better models. SandboxAQ is betting that access is the bigger obstacle and that Claude solves it.

Supercharging Immune Cells May Help Control HIV Long-Term
CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV.


